Agilon Health, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report a combined beneficial ownership of 4.15% in agilon health, Inc. following an amendment to their Schedule 13G filing.
NYSE
Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Agilon Health, Inc. common stock.
NYSE
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, reporting beneficial ownership of 974,897 shares of agilon health, Inc. common stock, representing 5.87% of the class.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, disclosing beneficial ownership of 6.1% of Agilon Health, Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amendment to its Schedule 13G for agilon health Inc., reporting a beneficial ownership of 4.41% of common stock as of December 31, 2025.
NYSE
North Peak Capital Management, LLC and its affiliated entities have disclosed a beneficial ownership of 9.5% in agilon health, inc., totaling 39,411,957 shares.
NYSE
FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 3.7% in Agilon Health Inc.'s common stock.
NYSE
The Vanguard Group reported a 5.86% beneficial ownership stake in agilon health Inc., holding over 24 million common shares as of September 30, 2025.
NYSE
Capital World Investors, an investment adviser, reported a 2.6% beneficial ownership stake in agilon health, Inc., holding 10,852,943 shares of common stock.
NYSE
North Peak Capital Management and affiliated entities have reported a passive 5.2% beneficial ownership stake in agilon health, Inc. through a Schedule 13G filing.
NYSE
Capital World Investors reports an 11.0% beneficial ownership stake in agilon health, Inc., holding over 45.5 million shares of common stock.
NYSE
Capital International Investors has filed an amended Schedule 13G, reporting a 2.4% beneficial ownership stake in agilon health, Inc. as of June 30, 2025.
NYSE
FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 9.4% in Agilon Health Inc.'s common stock as of June 30, 2025.
NYSE
Capital World Investors, a division of Capital Research and Management Company, has reported a 13.0% passive beneficial ownership stake in agilon health, Inc., holding over 53.4 million shares.
NYSE
SCHEDULE 13G/A: Wellington Management Entities Disclose 3.6% Stake in agilon health, Inc. via Amended 13G Filing
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a beneficial ownership of 3.6% in agilon health, Inc. common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: Morgan Stanley Discloses 12.2% Passive Stake in agilon health, Inc. via Amended Schedule 13G
Morgan Stanley and its wholly-owned subsidiary, Morgan Stanley Investment Management Inc., have filed an amended Schedule 13G disclosing a combined beneficial ownership of 12.2% of agilon health, Inc.'s common stock as of March 31, 2025.
NYSE
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a collective beneficial ownership of 6.88% of agilon health, Inc.'s common stock as of February 28, 2025.
NYSE
Capital International Investors has disclosed a 5.4% beneficial ownership stake in agilon health, Inc., holding 22,331,873 shares of common stock as of December 31, 2024.